Your browser is no longer supported. Please, upgrade your browser.
Settings
BLPH Bellerophon Therapeutics, Inc. daily Stock Chart
BLPH [NASD]
Bellerophon Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.60 Insider Own4.50% Shs Outstand32.04M Perf Week-15.38%
Market Cap42.29M Forward P/E- EPS next Y-1.15 Insider Trans1.41% Shs Float28.69M Perf Month-11.41%
Income-23.80M PEG- EPS next Q- Inst Own56.10% Short Float9.06% Perf Quarter137.41%
Sales- P/S- EPS this Y58.20% Inst Trans113.34% Short Ratio1.49 Perf Half Y-7.04%
Book/sh0.89 P/B1.48 EPS next Y-17.30% ROA-86.60% Target Price5.00 Perf Year-49.23%
Cash/sh0.63 P/C2.10 EPS next 5Y- ROE-119.10% 52W Range0.43 - 4.58 Perf YTD153.85%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-71.18% Beta-
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low204.85% ATR0.26
Employees22 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)49.95 Volatility24.37% 20.23%
OptionableNo Debt/Eq0.00 EPS Q/Q55.80% Profit Margin- Rel Volume0.34 Prev Close1.41
ShortableYes LT Debt/Eq0.00 EarningsMar 20 BMO Payout- Avg Volume1.75M Price1.32
Recom2.00 SMA20-9.84% SMA5028.64% SMA2004.87% Volume588,900 Change-6.38%
Jan-20-17Initiated H.C. Wainwright Buy $5
Mar-22-16Reiterated Leerink Partners Outperform $11 → $9
Jul-27-15Reiterated FBR Capital Outperform $23 → $11
Mar-16-15Initiated FBR Capital Outperform $23
Mar-21-17 09:30AM  The Difference Between Spectacular News and No News Accesswire
Mar-16-17 01:04PM  BELLEROPHON THERAPEUTICS, INC. Financials -5.13%
06:15AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
Mar-13-17 08:47AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
07:52AM  Bellerophon Therapeutics posts 4Q loss
07:30AM  Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
06:20AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
Feb-23-17 08:10AM  LifeSci Capital Initiates Coverage of Bellerophon Therapeutics Accesswire -7.69%
Jan-20-17 07:15AM  Coverage initiated on Bellerophon Therapeutics by H.C. Wainwright +5.51%
Jan-06-17 05:18PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Jan-04-17 08:38AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +16.45%
08:00AM  Bellerophon Therapeutics Announces FDA Acceptance of Modifications to INOpulse Pulmonary Arterial Hypertension Phase 3 Program GlobeNewswire
Dec-22-16 01:10PM  These 5 Stocks Under $10 Could Make You a Lot of Money
Dec-12-16 05:26PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-29-16 05:11PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
Nov-23-16 06:30AM  Bellerophon Therapeutics, Inc. Announces $12 Million Public Offering GlobeNewswire -26.00%
Nov-15-16 05:09PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or
Nov-09-16 10:21AM  Bellerophon Therapeutics posts 3Q loss
Nov-08-16 07:08AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement -6.86%
07:03AM  Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
06:40AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
Nov-01-16 02:09PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Bellerophon Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
12:50PM  Robbins Arroyo LLP is Investigating the Officers and Directors of Bellerophon Therapeutics, Inc. (BLPH) on Behalf of Shareholders Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bellerophon Therapeutics, Inc. (BLPH) PR Newswire
Oct-31-16 08:00AM  Second Law Firm Hits Bellerophon (BLPH) at Investopedia
Oct-28-16 12:19PM  INVESTOR ALERT: Investigation of Bellerophon Therapeutics, Inc. Announced by Law Offices of Howard G. Smith Business Wire -8.00%
Oct-26-16 01:29PM  Law Firm Targets Bellerophon Therapeutics (BLPH) at Investopedia -14.86%
09:02AM  Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics, Inc., KemPharm, Inc., Neos Therapeutics, Inc., CommVault Systems, Inc. and Resource Capital Corp. PR Newswire
Sep-20-16 06:54AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
06:33AM  Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 GlobeNewswire
Sep-06-16 06:37AM  Bellerophon to Present at the 18th Annual Rodman & Renshaw Global Investment Conference GlobeNewswire -9.03%
Aug-09-16 07:02AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
06:41AM  Bellerophon Therapeutics posts 2Q loss
06:33AM  Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
Jul-27-16 07:54AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.68%
Jul-25-16 12:05PM  Bellerophon Gets Approval To Start Second Stage Study In PH-COPD
06:03AM  Bellerophon Receives Approval to Commence Phase 2 Trial in PH-COPD GlobeNewswire
Jun-17-16 04:53PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-16-16 06:44AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:03AM  Bellerophon Therapeutics Announces Enrollment of the First Patient in the INOvation-1 Phase 3 Clinical Trial for Pulmonary Arterial Hypertension (PAH) GlobeNewswire
May-27-16 04:34PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
May-13-16 07:49AM  6 Stocks Under $10 Making Big Moves Higher at TheStreet
May-10-16 07:17AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement -9.68%
06:46AM  Bellerophon Therapeutics posts 1Q loss
06:33AM  Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
06:15AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
Mar-21-16 09:44AM  Edited Transcript of BLPH earnings conference call or presentation 21-Mar-16 12:30pm GMT
08:30AM  Bellerophon Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2015 Bellerophon Therapeutics Inc Earnings Release - Before Market Open
06:37AM  Bellerophon Reports 2015 Financial Results and Provides Business Update at noodls
06:30AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
06:03AM  Bellerophon Reports 2015 Financial Results and Provides Business Update GlobeNewswire
Mar-14-16 08:03AM  Bellerophon Therapeutics to Hold Full Year 2015 Financial Results Conference Call on Monday March 21, 2016 GlobeNewswire
Mar-04-16 05:33PM  Bellerophon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference GlobeNewswire +14.84%
Mar-02-16 08:03AM  Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Feb-23-16 03:41PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
08:03AM  Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer GlobeNewswire
Feb-18-16 08:25AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-16-16 08:03AM  Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member GlobeNewswire +6.90%
Feb-09-16 08:03AM  Bellerophon Therapeutics Announces Positive Data From the Final Analysis of the Phase 2 Long-Term Extension Study of INOpulse for Treatment of Pulmonary Arterial Hypertension GlobeNewswire +43.43%
Feb-03-16 08:03AM  Bellerophon to Participate in LEERINK Partners 5th Annual Global Healthcare Conference GlobeNewswire
Jan-21-16 08:03AM  Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program GlobeNewswire
Jan-19-16 08:03AM  Bellerophon Therapeutics Receives EC Certification for New INOpulse┬« Drug-Device Delivery System GlobeNewswire
08:00AM  MicroCap Review Magazine Winter/Spring 2016 Issue Now Available Marketwired
Jan-12-16 05:01PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
Dec-13-15 11:25AM  The Best and Worst IPO's of 2015 at Motley Fool
Dec-04-15 04:32PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
Nov-30-15 05:14PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-16-15 10:48AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
Nov-12-15 08:40AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
06:03AM  Bellerophon Reports 2015 Third Quarter Operational and Financial Results GlobeNewswire
Oct-01-15 08:17AM  Due Diligence Report: Phase 2 Success; Phase 3 the Real Test Accesswire -14.26%
Sep-30-15 04:08PM  Squashed Takeovers And Positive Test Results Propelling These Stocks Higher at Insider Monkey +25.97%
07:03AM  Bellerophon Announces Functional Respiratory Imaging Data From Company Sponsored Clinical Trial of INOpulse(R) in COPD Patients With Pulmonary Hypertension Presented Today at the European Respiratory Society (ERS) International Congress GlobeNewswire
Sep-29-15 01:54PM  Hedge Funds Disagree with the Market on One of These Two Falling Stocks at Insider Monkey -13.26%
Sep-25-15 03:30PM  Bellerophon Presents Positive Interim Data on INOpulse +69.35%
02:46PM  These Stocks Are Surging but See Which Ones Hedge Funds Think are Worth Investing In at Insider Monkey
09:00AM  Bellerophon Therapeutics, Inc. Conference Call to discuss Positive Data from Interim Analysis of Phase 2 Long-Term Extension Study of INOpulse(R) for Treatment of Pulmonary Arterial Hypertension scheduled for 9:00 am ET today
08:01AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Sep-24-15 05:02PM  Bellerophon shares skyrocket on high blood pressure drug study at MarketWatch
04:30PM  Bellerophon Therapeutics Announces Positive Data From Interim Analysis of Phase 2 Long-Term Extension Study of INOpulse(R) for Treatment of Pulmonary Arterial Hypertension GlobeNewswire
Sep-22-15 08:00AM  StockNewsNow.com Publishes New SNNLive Video Interview with Bellerophon Therapeutics, Inc. Marketwired
Sep-17-15 04:32PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Direc
Sep-15-15 08:07AM  Bellerophon Therapeutics Announces Leadership Team Changes GlobeNewswire
Sep-09-15 08:02AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Sep-03-15 04:23PM  Bellerophon to Present in Upcoming Investor Conferences GlobeNewswire +6.83%
Aug-18-15 04:20PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement +8.93%
Aug-17-15 02:03PM  5 Stocks Ready for Breakouts at TheStreet +11.72%
Aug-14-15 07:18AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report +19.70%
Aug-13-15 06:33PM  Bellerophon Reports 2015 Second Quarter Operational and Financial Results GlobeNewswire +9.12%
Aug-12-15 04:32PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement -7.53%
Aug-10-15 02:08PM  IBB claws its way back
Jul-31-15 04:55PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Jul-29-15 06:03AM  Bellerophon Therapeutics Expands License Agreement With INO Therapeutics to Develop INOpulse(R) for Three Additional Cardiopulmonary Diseases GlobeNewswire
Jul-27-15 12:19PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Bellerophon Therapeutics LLC and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws Business Wire -55.69%
08:30AM  Sanchez Energy Corp Earnings Call scheduled for 8:30 am ET today
08:03AM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Discl
06:36AM  Bellerophon's heart device fails study
06:00AM  Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix (BCM) GlobeNewswire
Jul-15-15 04:31PM  BELLEROPHON THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates include INOpulse, a pulsatile nitric oxide delivery device, which has completed Phase II clinical trials for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luehring JensDirectorDec 09Buy0.5620,00011,20039,860Dec 12 10:10 AM